FEASIBILITY STUDY OF A PERSONALIZED AND ADAPTABLE CANCER VACCINE FOR PATIENTS WITH GLIOBLASTOMA.
PI: Duane A. Mitchell, M.D., Ph.D.
Assistant Professor of Neurosurgery
Associate Director, Duke Brain Tumor Immunotherapy Program
The Preston Robert Tisch Brain Tumor Center at Duke